$11.96
-0.04[-0.33%]
At close: May 31
$12.00
0.0400[0.33%]
After Hours: 4:00PM EDT
Alto Neuroscience
(NYSE:ANRO)Alto Neuroscience Stock (NYSE:ANRO), Quotes and News Summary
Alto Neuroscience Stock (NYSE: ANRO) stock price, news, charts, stock research, profile.
| Open | $12.380 |
| Close | $11.960 |
| Volume / Avg. | 63.668K / 159.973K |
| Day Range | 11.920 - 12.380 |
| 52 Wk Range | 11.680 - 24.000 |
| Market Cap | $321.533M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NYSE |
| RSI | 40 |
| Short Interest | 12.23% |
| Days to Cover | 28.87 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Alto Neuroscience (ANRO) stock?
You can purchase shares of Alto Neuroscience (NYSE: ANRO) through any online brokerage.
Who are Alto Neuroscience's (ANRO) competitors?
Other companies in Alto Neuroscience’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH) and SNDL (NASDAQ:SNDL).
What is the target price for Alto Neuroscience (ANRO) stock?
The latest price target for Alto Neuroscience (NYSE: ANRO) was reported by Stifel on Monday, March 25, 2024. The analyst firm set a price target for 32.00 expecting ANRO to rise to within 12 months (a possible 166.67% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Alto Neuroscience (ANRO)?
The stock price for Alto Neuroscience (NYSE: ANRO) is $12 last updated May 30, 2024 at 4:00 PM EDT.
Does Alto Neuroscience (ANRO) pay a dividend?
There are no upcoming dividends for Alto Neuroscience.
When is Alto Neuroscience (NYSE:ANRO) reporting earnings?
Alto Neuroscience’s Q2 earnings are confirmed for Friday, August 2, 2024.
Is Alto Neuroscience (ANRO) going to split?
There is no upcoming split for Alto Neuroscience.
What sector and industry does Alto Neuroscience (ANRO) operate in?
Alto Neuroscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.